↓ Skip to main content

Pancreatic enzyme replacement therapy for people with cystic fibrosis

Overview of attention for article published in this source, October 2014
Altmetric Badge

Mentioned by

1 policy source
11 tweeters
1 Wikipedia page


18 Dimensions

Readers on

59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Pancreatic enzyme replacement therapy for people with cystic fibrosis
Published by
John Wiley & Sons, Ltd, October 2014
DOI 10.1002/14651858.cd008227.pub2
Pubmed ID

Somaraju, Usha Rani, Solis-Moya, Arturo


Most people with cystic fibrosis (80% to 90%) need pancreatic enzyme replacement therapy to prevent malnutrition. Enzyme preparations need to be taken whenever food is taken, and the dose needs to be adjusted according to the food consumed. A systematic review on the efficacy and safety of pancreatic enzyme replacement therapy is needed to guide clinical practice, as there is variability between centres with respect to assessment of pancreatic function, time of commencing treatment, dose and choice of supplements.

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Spain 1 2%
South Africa 1 2%
Unknown 56 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 20%
Student > Ph. D. Student 11 19%
Researcher 8 14%
Student > Bachelor 7 12%
Other 5 8%
Other 8 14%
Unknown 8 14%
Readers by discipline Count As %
Medicine and Dentistry 24 41%
Social Sciences 4 7%
Nursing and Health Professions 4 7%
Biochemistry, Genetics and Molecular Biology 3 5%
Agricultural and Biological Sciences 3 5%
Other 11 19%
Unknown 10 17%